$ACEL
Accel Entertainment, Inc.

2018 Q3 Form 10-Q Financial Statement

#000156459018026866 Filed on November 05, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q4 2017 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $100.0K $200.0K $100.0K
YoY Change 0.0%
Operating Profit -$137.7K -$94.40K
YoY Change 45.85%
Interest Expense $2.100M $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.931M -$157.4K -$94.40K
YoY Change -2146.06%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings $1.900M -$200.0K -$100.0K
YoY Change -2000.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $33.75K -$3.322K -$1.773K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.0K $400.0K $1.600M
YoY Change -68.75%
Cash & Equivalents $512.8K $372.1K $1.637M
Short-Term Investments
Other Short-Term Assets $100.0K $100.0K $200.0K
YoY Change -50.0%
Inventory
Prepaid Expenses $134.7K $165.4K
Receivables
Other Receivables
Total Short-Term Assets $585.6K $506.8K $1.802M
YoY Change -67.5%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $454.5M $450.0M $450.0M
YoY Change 1.0%
Total Long-Term Assets $454.5M $450.0M $450.0M
YoY Change 1.01%
TOTAL ASSETS
Total Short-Term Assets $585.6K $506.8K $1.802M
Total Long-Term Assets $454.5M $450.0M $450.0M
Total Assets $455.1M $450.5M $451.8M
YoY Change 0.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $78.74K $157.4K $1.295M
YoY Change -93.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $78.74K $157.4K $1.295M
YoY Change -93.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $15.80M $15.80M $15.80M
YoY Change 0.0%
Total Long-Term Liabilities $15.80M $15.80M $15.80M
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $78.74K $157.4K $1.295M
Total Long-Term Liabilities $15.80M $15.80M $15.80M
Total Liabilities $15.83M $15.91M $17.05M
YoY Change -7.14%
SHAREHOLDERS EQUITY
Retained Earnings $4.316M -$376.4K -$218.9K
YoY Change -2071.75%
Common Stock $682.4K $5.375M $5.218M
YoY Change -86.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M $44.53M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $455.1M $450.5M $451.8M
YoY Change 0.73%

Cashflow Statement

Concept 2018 Q3 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income $1.900M -$200.0K -$100.0K
YoY Change -2000.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $370.0K -$410.0K -$40.00K
YoY Change -1025.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -850.0K -260.0K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 370.0K -410.0K -40.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 -850.0K -260.0K
Net Change In Cash 370.0K -1.260M -300.0K
YoY Change -223.33%
FREE CASH FLOW
Cash From Operating Activities $370.0K -$410.0K -$40.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Cash
Cash
512827
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
134722
CY2018Q3 us-gaap Assets Current
AssetsCurrent
585572
CY2017Q4 us-gaap Assets Current
AssetsCurrent
506795
CY2018Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
454535412
CY2017Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
450000000
CY2018Q3 us-gaap Assets
Assets
455120984
CY2017Q4 us-gaap Assets
Assets
450506795
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78742
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
157390
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
78742
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
157390
CY2018Q3 us-gaap Registration Payment Arrangement Maximum Potential Consideration
RegistrationPaymentArrangementMaximumPotentialConsideration
15750000
CY2017Q4 us-gaap Registration Payment Arrangement Maximum Potential Consideration
RegistrationPaymentArrangementMaximumPotentialConsideration
15750000
CY2018Q3 us-gaap Liabilities
Liabilities
15828742
CY2017Q4 us-gaap Liabilities
Liabilities
15907390
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
434292240
CY2017Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
429599400
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Small Business
EntitySmallBusiness
false
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-218915
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.08
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56250000
CY2018Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
137687
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5285412
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
157
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
204
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
682255
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5375048
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4316465
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-376372
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
5000002
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
5000005
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
455120984
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
450506795
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
94400
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
592575
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
218938
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-137687
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-94400
us-gaap Operating Income Loss
OperatingIncomeLoss
-592575
us-gaap Operating Income Loss
OperatingIncomeLoss
-218938
CY2018Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2069168
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
23
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1931481
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-94400
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4692837
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-218915
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56369565
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56250000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29320961
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
11000000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9000000
tpgh Adjustments To Additional Paid In Capital Stock Deferred Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockDeferredOfferingCosts
1299223
tpgh Deferred Underwriting Compensation
DeferredUnderwritingCompensation
15750000
tpgh Stock Issued During Period Capitalization Value Forfeited To Additional Paid In Capital
StockIssuedDuringPeriodCapitalizationValueForfeitedToAdditionalPaidInCapital
0
tpgh Stockholders Equity Reclassification To From Temporary Equity Value
StockholdersEquityReclassificationToFromTemporaryEquityValue
429756860
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
5000002
tpgh Stockholders Equity Reclassification To From Temporary Equity Value
StockholdersEquityReclassificationToFromTemporaryEquityValue
4692840
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4692837
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-61977
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
165429
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
11099
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
323987
us-gaap Investment Income Interest
InvestmentIncomeInterest
5285412
us-gaap Investment Income Interest
InvestmentIncomeInterest
0
tpgh Trust Account Interest Withdrawal To Pay Operating Expenses
TrustAccountInterestWithdrawalToPayOperatingExpenses
750000
tpgh Trust Account Interest Withdrawal To Pay Operating Expenses
TrustAccountInterestWithdrawalToPayOperatingExpenses
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
230501
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60357
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
0
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
450000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-450000000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
450000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
11000000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
300000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
9000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-89747
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-328100
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-89747
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
451696900
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
140754
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1636543
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
372073
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
512827
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1636543
tpgh Deferred Underwriting Compensation Amount
DeferredUnderwritingCompensationAmount
0
tpgh Deferred Underwriting Compensation Amount
DeferredUnderwritingCompensationAmount
15750000
tpgh Accrued Offering Cost
AccruedOfferingCost
0
tpgh Accrued Offering Cost
AccruedOfferingCost
971123
CY2017Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
450000000
CY2017Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
11000000
tpgh Trust Account Interest Withdrawal Annual Limit To Fund Working Capital And Tax Payment
TrustAccountInterestWithdrawalAnnualLimitToFundWorkingCapitalAndTaxPayment
750000
tpgh Trust Account Threshold For Release Of Funds
TrustAccountThresholdForReleaseOfFunds
1.00
tpgh Remaining Proceeds Held Outside Trust Account
RemainingProceedsHeldOutsideTrustAccount
2000000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p></div>
tpgh Repayments On Loans
RepaymentsOnLoans
300000
CY2018Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2018Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with U.S.&#160;GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p></div>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2017-02-14
tpgh Public Offering Closing Date
PublicOfferingClosingDate
2017-06-30
tpgh Term For Completion Of Business Acquisition
TermForCompletionOfBusinessAcquisition
The Company has 24 months from the Close Date, or 27 months from the Close Date if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial business combination within 24 months of the Close Date, to complete its Business Combination. If the Company does not complete a Business Combination within this period, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds in the Trust Account and not previously released to the Company to fund its working capital requirements, subject to an annual limit of $750,000, and/or to pay its taxes (less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Company’s Sponsor and four independent directors (collectively, “Initial Shareholders”) and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to their Founder Shares (as defined in Note 4) if the Company fails to complete the Business Combination within 24 months from the Close Date, or 27 months from the Close Date if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial business combination within 24 months of the Close Date. However, if the Initial Shareholders acquire public shares after the Close Date, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete the Business Combination within the allotted 24-month time period, or 27 months from the Close Date
CY2018Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q3 tpgh Maximum Underwriter Discount
MaximumUnderwriterDiscount
24750000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2069168
CY2018Q3 tpgh Trust Account Interest Withdrawal To Pay Operating Expenses
TrustAccountInterestWithdrawalToPayOperatingExpenses
750000
CY2018Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
0
us-gaap Underwriting Commitments
UnderwritingCommitments
no Deferred Discount is payable to the underwriters if a Business Combination is not completed within 24 months after the Close Date, or 27 months from the Close Date if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial business combination within 24 months of the Close Date.

Files In Submission

Name View Source Status
0001564590-18-026866-index-headers.html Edgar Link pending
0001564590-18-026866-index.html Edgar Link pending
0001564590-18-026866.txt Edgar Link pending
0001564590-18-026866-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpgh-10q_20180930.htm Edgar Link pending
tpgh-20180930.xml Edgar Link completed
tpgh-20180930.xsd Edgar Link pending
tpgh-20180930_cal.xml Edgar Link unprocessable
tpgh-20180930_def.xml Edgar Link unprocessable
tpgh-20180930_lab.xml Edgar Link unprocessable
tpgh-20180930_pre.xml Edgar Link unprocessable
tpgh-ex311_8.htm Edgar Link pending
tpgh-ex312_7.htm Edgar Link pending
tpgh-ex321_6.htm Edgar Link pending
tpgh-ex322_9.htm Edgar Link pending